According to Dong C’s [15] study, hypokalemia was prevailing in patients with COVID-19, and the correction of hypokalemia was challenging because of continuous renal K+ loss resulting from the degradation of ACE2. The gene discussed is ACE2; the disease is Hypokalemia.